Cargando…
Development of neuroactive steroids for the treatment of postpartum depression
Postpartum depression (PPD) is a common major depressive episode surrounding childbirth, with estimated rates ranging from 5.5% to 23.5% of all live births across Europe and the USA based on the presence of key symptoms. PPD has been associated with significant impairments in both maternal functioni...
Autores principales: | Gunduz‐Bruce, Handan, Takahashi, Koji, Huang, Ming‐Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285576/ https://www.ncbi.nlm.nih.gov/pubmed/34462985 http://dx.doi.org/10.1111/jne.13019 |
Ejemplares similares
-
Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression
por: Maguire, Jamie
Publicado: (2019) -
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants
por: Kaufman, Yardana, et al.
Publicado: (2022) -
Analytical Methods for the Determination of Neuroactive Steroids
por: Kaleta, Michal, et al.
Publicado: (2021) -
Physiopathological Role of Neuroactive Steroids in the Peripheral Nervous System
por: Falvo, Eva, et al.
Publicado: (2020) -
The Role of Neuroactive Steroids in Analgesia and Anesthesia: An Interesting Comeback?
por: Jevtovic-Todorovic, Vesna, et al.
Publicado: (2023)